THC Therapeutics, Inc. (THCT)
THC Therapeutics, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Jacksboro, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $23,320. On trailing twelve-month figures it carries a trailing P/E of -0.05, a net margin of 0.0%. Its beta of 7.53 implies it has historically moved more than the broad market.
THC Therapeutics, Inc. is a company active in the wellness sector, primarily engaged in developing the dHydronator. This innovative device functions as a sanitizing herb dryer, specifically designed for the efficient drying and cleansing of freshly harvested cannabis, as well as a variety of other herbs, flowers, and tea leaves. Established in 2007, the organization was initially known as Millennium Blockchain, Inc. before officially changing its name to THC Therapeutics, Inc. in September 2018. The company's corporate headquarters are located in Las Vegas, Nevada.
THC Therapeutics, Inc. is most often compared with the following Healthcare names: